About REMATIQ
REMATIQ is a company based in Berlin (Germany) founded in 2023 by David Boutellier and Florian Scherer. REMATIQ has raised $6.13 million across 1 funding round from investors including Project A, Amino Collective and HelloWorld VC. REMATIQ offers products and services including Requirement Extraction, End-to-End Traceability, and Automated Change Processing. REMATIQ operates in a competitive market with competitors including Advarra, Leucine, PHARMASEAL, Datapharm and Flinn, among others.
- Headquarter Berlin, Germany
- Founders David Boutellier, Florian Scherer
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Rematiq Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$6.13 M (USD)
in 1 rounds
-
Latest Funding Round
$6.13 M (USD), Seed
Apr 11, 2025
-
Investors
Project A
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of REMATIQ
REMATIQ offers a comprehensive portfolio of products and services, including Requirement Extraction, End-to-End Traceability, and Automated Change Processing.
Automates extraction and simplification of regulatory requirements from documents.
Provides full traceability for product lifecycle and audit readiness.
Identifies and processes regulatory updates to minimize manual effort.
Funding Insights of REMATIQ
REMATIQ has successfully raised a total of $6.13M through 1 strategic funding round. The most recent funding activity was a Seed round of $6.13 million completed in April 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in REMATIQ
REMATIQ has secured backing from 5 investors, including venture fund and angel investors. Prominent investors backing the company include Project A, Amino Collective and HelloWorld VC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Project A is recognized as an early-stage venture capital firm focused on European startups.
|
Locked | Locked | Locked | |
|
Amino Collective is engaged in backing innovative startup founders.
|
Locked | Locked | Locked | |
|
Early-stage venture capital firm primarily investing in the US
|
Locked | Locked | Locked |
Investor details for REMATIQ
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by REMATIQ
Investment portfolio details for REMATIQ
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - REMATIQ
Detailed financials for REMATIQ
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Rematiq Comparisons
Peer comparison for REMATIQ
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of REMATIQ
REMATIQ operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Advarra, Leucine, PHARMASEAL, Datapharm and Flinn, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Global research compliance services including IRB and consulting are provided.
|
|
| Locked | Locked | Locked |
Developer of AI-powered software for pharmaceutical manufacturing, quality, and laboratory
|
|
| Locked | Locked | Locked |
SaaS platform for biopharmaceutical clinical trial management is offered.
|
|
| Locked | Locked | Locked |
Regulatory compliance software for pharma and healthcare professionals is provided.
|
|
| Locked | Locked | Locked |
Compliance processes are automated for medical device manufacturers using AI.
|
|
| Locked | Locked | Locked |
Enterprise terminology management for medical coding is offered.
|
Detailed competitors of REMATIQ
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Rematiq
Complete news archive for REMATIQ
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about REMATIQ
REMATIQ was founded in 2023 and raised its 1st funding round 2 years after it was founded.
REMATIQ is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.
David Boutellier is the current CEO of REMATIQ. They have also founded this company.
REMATIQ is a funded company, having raised a total of $6.13M across 1 funding round to date.
Founded in 2023 and based in Berlin, Germany, REMATIQ operates within the life sciences industry. An AI-native platform is utilized to automate regulatory tasks, with compliance simplified for companies. Complexity is reduced and efficiency is increased through these processes, supporting operations across the sector. Key leadership includes co-founders David Boutellier as CEO and Florian Scherer as CTO.
REMATIQ's top competitors include Advarra, PHARMASEAL and Flinn.
REMATIQ offers Requirement Extraction, End-to-End Traceability, and Automated Change Processing.
REMATIQ has 5 investors. Key investors include Project A, Amino Collective, HelloWorld VC, Boris Lokschin, and Timo Flebner.